Durability of RSV Antibodies Following RSV Vaccination in Solid Organ Transplant Recipients
Year: 2025
Type: article
Abstract: Purpose: Solid organ transplant recipients (SOTRs) are at high risk for severe respiratory syncytial virus (RSV) infection and demonstrate variable vaccine responses. In healthy populations, antibody (Ab) response and clinical protection last for >1 year following a single vaccine dose, yet Ab durability in SOTRs is not known and may inform role for additional doses.
Authors: C. Hage, I. Sengsouk, P. Balasubramanian, X. Green, W. Gallo, J. Xue, M. Chahoud, D. Segev, A. Tobian, W. Werbel, A. Karaba
Institutions: Johns Hopkins University, NYU Langone Health
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,300
OpenAlex ID: W4412850685